UBS Group’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-70,000
Closed -$6.6M 9515
2023
Q2
$6.6M Hold
70,000
﹤0.01% 2315
2023
Q1
$6.96M Buy
+70,000
New +$6.89M ﹤0.01% 2211
2020
Q2
Sell
-55,800
Closed -$3.69M 7969
2020
Q1
$3.69M Buy
55,800
+35,800
+179% +$2.57M ﹤0.01% 2195
2019
Q4
$1.56M Buy
+20,000
New +$1.59M ﹤0.01% 3794
2017
Q4
Sell
-333,000
Closed -$25.3M 7857
2017
Q3
$25.3M Buy
+333,000
New +$23.1M 0.01% 964
2016
Q1
Sell
-200
Closed -$12K 7671
2015
Q4
$12K Sell
200
-18,500
-99% -$1.25M ﹤0.01% 7163
2015
Q3
$1.27M Buy
18,700
+4,660
+33% +$313K ﹤0.01% 3138
2015
Q2
$876K Buy
14,040
+715
+5% +$47.1K ﹤0.01% 3675
2015
Q1
$976K Sell
13,325
-2,600
-16% -$190K ﹤0.01% 3602
2014
Q4
$1.19M Buy
+15,925
New +$1.14M ﹤0.01% 3424

Other funds holding CHRW

UBS Group's CHRW Position: Q1 2026 in Review

UBS Group increased its C.H. Robinson (CHRW) stake by 121% in Q1 2026, buying an estimated $158M and bringing the position to 1,608,274 shares worth $267M. The position accounts for 0.04% of the portfolio, ranked #480.

UBS Group first reported a position in CHRW in Q4 2014 and has held it in 46 quarters since. 883 funds tracked by Wall St. Rank hold CHRW as of Q1 2026.

  • UBS Group held 1,608,274 shares of C.H. Robinson worth $267M as of Q1 2026.
  • UBS Group bought 881,389 C.H. Robinson shares in Q1 2026, an estimated $158M.
  • C.H. Robinson made up 0.04% of UBS Group's portfolio in Q1 2026, its #480 holding.
  • UBS Group first reported a position in C.H. Robinson in Q4 2014 and has held it in 46 quarters since.
  • 883 funds tracked by Wall St. Rank held C.H. Robinson as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.